Group leader (DR2 Inserm)
Equipe : intégrité de l épigenome
Téléphone : +33 (0)1 57 27 89 81
Pièce n°: 413
Sophie graduated from the Ecole Normale Supérieure de Paris in 2002. She received her PhD in 2006 from Paris VI University, working with Geneviève Almouzni at the Institut Curie in Paris on the role of chromatin assembly factors in cell proliferation and genome stability. She then joined Steve Jackson’s laboratory at the Gurdon Institute in Cambridge UK for her postdoctoral studies. There, she developed an interest in the response to DNA breaks and characterized the function of chromatin remodelers in this context. Back in France, she obtained a permanent staff scientist position (CR2 Inserm) in 2011, and she was awarded the Olga Sain prize from la Ligue contre le Cancer in the same year. Sophie established her own group at the Epigenetics and Cell Fate Centre in 2013 on Paris Diderot University campus, with the support of the ANR young investigator program followed by a Starting Grant from the European Research Council. Sophie was selected EMBO young Investigator in 2017 and promoted research director (DR2 Inserm) in 2018.